#ASCO24
I can't wait to learn from all the work performed on #oncology WW 🌍
🤩 Many promising drugs 💊💉are coming into clinics
🤜🏼 Here is my personal selection of #drugdevelopment
ASCO OncoAlert Oncology Brothers ESMO - Eur. Oncology SEOM Conquer Cancer, the ASCO Foundation
Shortages of critical cancer drugs leave oncology care providers facing impossible choices about patient care. We need your voice to end cancer #drugshortages .
Sign our Open Letter and urge Congress and the administration to act: brnw.ch/21wKfV0 #ASCOAdvocacy #ASCO24
Amazing symposium 👏🏼 “Exercise Oncology: a heart-to-heart overview” Christina Dieli-Conwright, PhD, MPH Rebekah Wilson The Dieli-Conwright Laboratory American College of Sports Medicine
Meet the scientific committee for #MAP2024 👇
One of this year's co-chairs is Mariam Jamal-Hanjani, principal investigator on the #CRUKFunded #TRACERx study providing novel insights into how we treat lung cancer. Register now 👉 bit.ly/3UWNR0v
CRUK Lung Centre | UCL Cancer Institute
New from the May issue—
Large-scale pan-cancer cell line screening identifies actionable and effective drug combinations, by Azadeh C. Bashi, Dr Elizabeth Coker, Krishna C Bulusu, Jerome T. Mettetal, Garnett Lab et al.
bit.ly/3V1ekd9
Wellcome Sanger Institute Oncology at AstraZeneca
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Clinical Cancer Research #Myeloma #Biomarkers #ASCO24
doi.org/10.1158/1078-0…